These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients. Neurath AR; Strick N; Li YY; Lin K; Jiang S Biologicals; 1999 Mar; 27(1):11-21. PubMed ID: 10441398 [TBL] [Abstract][Full Text] [Related]
3. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Thormar H; Bergsson G; Gunnarsson E; Georgsson G; Witvrouw M; Steingrímsson O; De Clercq E; Kristmundsdóttir T Sex Transm Infect; 1999 Jun; 75(3):181-5. PubMed ID: 10448397 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial peptides as microbicidal contraceptives: prophecies for prophylactics--a mini review. Yedery RD; Reddy KV Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):32-42. PubMed ID: 16036297 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive approach to in vitro functional evaluation of Ag/alginate nanocomposite hydrogels. Stojkovska J; Kostić D; Jovanović Ž; Vukašinović-Sekulić M; Mišković-Stanković V; Obradović B Carbohydr Polym; 2014 Oct; 111():305-14. PubMed ID: 25037356 [TBL] [Abstract][Full Text] [Related]
6. The future of microbicides. Omar RF; Bergeron MG Int J Infect Dis; 2011 Oct; 15(10):e656-60. PubMed ID: 21705253 [TBL] [Abstract][Full Text] [Related]
7. Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission. Nikolic DS; Piguet V J Invest Dermatol; 2010 Feb; 130(2):352-61. PubMed ID: 19829304 [TBL] [Abstract][Full Text] [Related]
8. HIV sexual transmission and microbicides. Ariën KK; Jespers V; Vanham G Rev Med Virol; 2011 Mar; 21(2):110-33. PubMed ID: 21412935 [TBL] [Abstract][Full Text] [Related]
9. Microbicides: putting women in control. Forbes A WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770 [TBL] [Abstract][Full Text] [Related]
10. Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases. Herold BC; Bourne N; Marcellino D; Kirkpatrick R; Strauss DM; Zaneveld LJ; Waller DP; Anderson RA; Chany CJ; Barham BJ; Stanberry LR; Cooper MD J Infect Dis; 2000 Feb; 181(2):770-3. PubMed ID: 10669374 [TBL] [Abstract][Full Text] [Related]
11. Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission. Friend DR Expert Opin Drug Deliv; 2012 Apr; 9(4):417-27. PubMed ID: 22385316 [TBL] [Abstract][Full Text] [Related]
12. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Venkatesh KK; van der Straten A; Mayer KH; Blanchard K; Ramjee G; Lurie MN; Chipato T; Padian NS; de Bruyn G Sex Transm Dis; 2011 Jun; 38(6):562-70. PubMed ID: 21278624 [TBL] [Abstract][Full Text] [Related]
13. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069 [TBL] [Abstract][Full Text] [Related]
14. Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1. Said J; Trybala E; Andersson E; Johnstone K; Liu L; Wimmer N; Ferro V; Bergström T Antiviral Res; 2010 Jun; 86(3):286-95. PubMed ID: 20307578 [TBL] [Abstract][Full Text] [Related]
15. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections. Nikolic DS; Garcia E; Piguet V Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456 [TBL] [Abstract][Full Text] [Related]
16. Biological activity assessment of a novel contraceptive antimicrobial agent. Garg A; Anderson RA; Zaneveld LJ; Garg S J Androl; 2005; 26(3):414-21. PubMed ID: 15867010 [TBL] [Abstract][Full Text] [Related]
17. Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2/HIV-1 co-infection. Guerrero-Beltrán C; Ceña-Diez R; Sepúlveda-Crespo D; De la Mata J; Gómez R; Leal M; Muñoz-Fernández MA; Jiménez JL Nanoscale; 2017 Nov; 9(44):17263-17273. PubMed ID: 29090302 [TBL] [Abstract][Full Text] [Related]
18. Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections - potential as a dual functional microbicide. Qiu M; Chen Y; Song S; Song H; Chu Y; Yuan Z; Cheng L; Zheng D; Chen Z; Wu Z Antiviral Res; 2012 Nov; 96(2):138-47. PubMed ID: 22940611 [TBL] [Abstract][Full Text] [Related]
19. Microbicide research and development--where to? Rustomjee R; Abdool Karim Q HIV Clin Trials; 2001; 2(3):185-92. PubMed ID: 11590526 [TBL] [Abstract][Full Text] [Related]